Human MageB2 protein expression enhances E2F transcriptional activity, cell proliferation, and resistance to ribotoxic stress

Journal of Biological Chemistry

Volumn 290, Issue 49, 2015, Pages 29652-29662

  Peche, Leticia Y ^a   Ladelfa, María F ^b   Toledo, María F ^b   Mano, Miguel ^c   Laiseca, Julieta E ^b   Schneider, Claudio ^a,d   Monte, Martín ^b  

^a Laboratorio Nazionale Consorzio Interuniversitario Per le Biotecnologie   (Italy)

^b Universidad de Buenos Aires   (Argentina)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^d UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELL PROLIFERATION; CELLS; CYTOLOGY; GENES; PROTEINS; TRANSCRIPTION; TUMORS;

CELL-CYCLE ARREST; CELLULAR DISTRIBUTIONS; DIFFERENT ORIGINS; FUNCTIONAL FEATURES; GENE EXPRESSION ANALYSIS; PROTEIN EXPRESSIONS; RIBOSOMAL PROTEINS; TRANSCRIPTIONAL ACTIVITY;

GENE EXPRESSION;

DACTINOMYCIN; HISTONE DEACETYLASE 1; MELANOMA ANTIGEN B2; PROTEIN MDM2; PROTEIN P53; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRICHOSTATIN A; TUMOR ANTIGEN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; GREEN FLUORESCENT PROTEIN; HDAC1 PROTEIN, HUMAN; HISTONE DEACETYLASE; MAGEB2 PROTEIN, HUMAN; MDM2 PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL PROLIFERATION; CELLULAR STRESS RESPONSE; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; EMBRYO; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL LINE; MOUSE; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; TUMOR GROWTH; ANIMAL; C57BL MOUSE; CELL CYCLE; CHEMISTRY; EXPERIMENTAL MELANOMA; FIBROBLAST; GENE EXPRESSION REGULATION; HCT 116 CELL LINE; HEK293 CELL LINE; METABOLISM; RIBOSOME;

ANIMALS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL NUCLEOLUS; CELL PROLIFERATION; DACTINOMYCIN; E2F TRANSCRIPTION FACTORS; FIBROBLASTS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HCT116 CELLS; HEK293 CELLS; HISTONE DEACETYLASE 1; HISTONE DEACETYLASES; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RIBOSOMES;

EID: 84949033255     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.671982     Document Type: Article

References (56)

1. Scanlan, M. J., Simpson, A. J., and Old, L. J. (2004) The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 4, 1
2. De Smet, C., Lurquin, C., Lethé, B., Martelange, V., and Boon, T. (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell. Biol. 19, 7327-7335
3. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647
4. Sang, M., Lian, Y., Zhou, X., and Shan, B. (2011) MAGE-A family: attractive targets for cancer immunotherapy. Vaccine 29, 8496-8500
5. Laduron, S., Deplus, R., Zhou, S., Kholmanskikh, O., Godelaine, D., De Smet, C., Hayward, S. D., Fuks, F., Boon, T., and De Plaen, E. (2004) MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. Nucleic Acids Res. 32, 4340-4350
6. Askew, E. B., Bai, S., Hnat, A. T., Minges, J. T., and Wilson, E. M. (2009) Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators. J. Biol. Chem. 284, 34793-34808
7. Bai, S., Grossman, G., Yuan, L., Lessey, B. A., French, F. S., Young, S. L., and Wilson, E. M. (2008) Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation. Mol. Hum. Reprod. 14, 107-116
8. Bai, S., He, B., and Wilson, E. M. (2005) Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction. Mol. Cell. Biol. 25, 1238-1257
9. Bai, S., andWilson, E.M.(2008)Epidermal-growth-factor-dependentphosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptor. Mol. Cell. Biol. 28, 1947-1963
10. Monte, M., Simonatto, M., Peche, L. Y., Bublik, D. R., Gobessi, S., Pierotti, M. A., Rodolfo, M., and Schneider, C. (2006) MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. Proc. Natl. Acad. Sci. U.S.A. 103, 11160-11165
11. Marcar, L., Maclaine, N. J., Hupp, T. R., and Meek, D. W. (2010) Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin. Cancer Res. 70, 10362-10370
12. Peche, L. Y., Scolz, M., Ladelfa, M. F., Monte, M., and Schneider, C. (2012) MageA2 restrains cellular senescence by targeting the function of PMLIV/ p53 axis at the PML-NBs. Cell Death Differ. 19, 926-936
13. Ladelfa, M. F., Peche, L. Y., Toledo, M. F., Laiseca, J. E., Schneider, C., and Monte, M. (2012) Tumor-specific MAGE proteins as regulators of p53 function. Cancer Lett. 325, 11-17
14. Gure, A. O., Chua, R., Williamson, B., Gonen, M., Ferrera, C. A., Gnjatic, S., Ritter, G., Simpson, A. J., Chen, Y. T., Old, L. J., and Altorki, N. K. (2005) Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clin. Cancer Res. 11, 8055-8062
15. Olarte, I., Martinez, A., Ramos-Peñafiel, C., Castellanos-Sinco, H., Zamora, J., Collazo-Jaloma, J., Gutiérrez, M., Gutiérrez-Kobeh, L., Chavez-Olmos, P., Manzanilla, H., Garrido-Guerrero, E., Ordoñez-Razo, R. M., and Miranda, E. I. (2011) MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma. Hematology 16, 368-372
16. Ogata, K., Aihara, R., Mochiki, E., Ogawa, A., Yanai, M., Toyomasu, Y., Ando, H., Ohno, T., Asao, T., and Kuwano, H. (2011) Clinical significance of melanoma antigen-encoding gene-1 (MAGE-1) expression and its correlation with poor prognosis in differentiated advanced gastric cancer. Ann. Surg. Oncol. 18, 1195-1203
17. Lian, Y., Sang, M., Ding, C., Zhou, X., Fan, X., Xu, Y., Lü, W., and Shan, B. (2012) Expressions of MAGE-A10 and MAGE-A11 in breast cancers and their prognostic significance: a retrospective clinical study. J. Cancer Res. Clin. Oncol. 138, 519-527
18. Sypniewska, R. K., Hoflack, L., Tarango, M., Gauntt, S., Leal, B. Z., Reddick, R. L., and Gravekamp, C. (2005) Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy. Breast Cancer Res. Treat. 91, 19-28
19. Yang, B., O'Herrin, S., Wu, J., Reagan-Shaw, S., Ma, Y., Nihal, M., and Longley, B. J. (2007) Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo. J. Invest. Dermatol. 127, 267-275
20. Yang, B., O'Herrin, S. M., Wu, J., Reagan-Shaw, S., Ma, Y., Bhat, K. M., Gravekamp, C., Setaluri, V., Peters, N., Hoffmann, F. M., Peng, H., Ivanov, A. V., Simpson, A. J., and Longley, B. J. (2007) MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res. 67, 9954-9962
21. Lin, Y., Wen, T., Meng, X., Wu, Z., Zhao, L., Wang, P., Hong, Z., and Yin, Z. (2012) The mouse Mageb18 gene encodes a ubiquitously expressed type I MAGE protein and regulates cell proliferation and apoptosis in melanoma B16-F0 cells. Biochem. J. 443, 779-788
22. Jang, S. J., Soria, J. C., Wang, L., Hassan, K. A., Morice, R. C., Walsh, G. L., Hong, W. K., and Mao, L. (2001) Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res. 61, 7959-7963
23. Pattani, K. M., Soudry, E., Glazer, C. A., Ochs, M. F., Wang, H., Schussel, J., Sun, W., Hennessey, P., Mydlarz, W., Loyo, M., Demokan, S., Smith, I. M., and Califano, J. A. (2012) MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma. PLoS ONE 7, e45534
24. van Duin, M., Broyl, A., de Knegt, Y., Goldschmidt, H., Richardson, P. G., Hop, W. C., van der Holt, B., Joseph-Pietras, D., Mulligan, G., Neuwirth, R., Sahota, S. S., and Sonneveld, P. (2011) Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy. Haematologica 96, 1662-1669
25. Krämer, B. F., Schoor, O., Krüger, T., Reichle, C., Müller, M., Weinschenk, T., Hennenlotter, J., Stenzl, A., Rammensee, H. G., and Stevanovic, S. (2005) MAGED4-expression in renal cell carcinoma and identification of an HLA-A∗25-restrictedMHCclass I ligand from solid tumor tissue. Cancer Biol. Ther. 4, 943-948
26. Müller, H., Moroni, M. C., Vigo, E., Petersen, B. O., Bartek, J., and Helin, K. (1997) Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol. Cell. Biol. 17, 5508-5520
27. Taniura, H., Taniguchi, N., Hara, M., and Yoshikawa, K. (1998) Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1. J. Biol. Chem. 273, 720-728
28. Kuwako, K., Taniura, H., and Yoshikawa, K. (2004) Necdin-relatedMAGE proteins differentially interact with the E2F1 transcription factor and the p75 neurotrophin receptor. J. Biol. Chem. 279, 1703-1712
29. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., and Harel-Bellan, A. (1998) Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601-605
30. Grandinetti, K. B., and David, G. (2008) Sin3B: an essential regulator of chromatin modifications at E2F target promoters during cell cycle withdrawal. Cell Cycle 7, 1550-1554
31. Wang, C., Rauscher, F. J., 3rd, Cress, W. D., and Chen, J. (2007) Regulation of E2F1 function by the nuclear corepressor KAP1. J. Biol. Chem. 282, 29902-29909
32. Zhang, Y., Woodford, N., Xia, X., and Hamburger, A. W. (2003) Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases. Nucleic Acids Res. 31, 2168-2177
33. Zhang, W., Ji, W., Liu, X., Ouyang, G., and Xiao, W. (2014) ELL inhibits E2F1 transcriptional activity by enhancing E2F1 deacetylation via recruitment of histone deacetylase 1. Mol. Cell. Biol. 34, 765-775
34. Galigniana, M. D., Harrell, J. M., O'Hagen, H. M., Ljungman, M., and Pratt, W. B. (2004) Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus. J. Biol. Chem. 279, 22483-22489
35. Cheng, S., Liu, W., Mercado, M., Ezzat, S., and Asa, S. L. (2009) Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer. Endocr. Relat. Cancer 16, 455-466
36. Zhou, X., Hao, Q., Liao, J. M., Liao, P., and Lu, H. (2013) Ribosomal protein S14 negatively regulates c-Myc activity. J. Biol. Chem. 288, 21793-21801
37. Lohrum, M. A., Ludwig, R. L., Kubbutat, M. H., Hanlon, M., and Vousden, K. H. (2003) Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3, 577-587
38. Donati, G., Brighenti, E., Vici, M., Mazzini, G., Treré, D., Montanaro, L., and Derenzini, M. (2011) Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. J. Cell Sci. 124, 3017-3028
39. Su, S., Minges, J. T., Grossman, G., Blackwelder, A. J., Mohler, J. L., and Wilson, E. M. (2013) Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins. J. Biol. Chem. 288, 24809-24824
40. Zhou, F., Zhang, L., Gong, K., Lu, G., Sheng, B., Wang, A., Zhao, N., Zhang, X., and Gong, Y. (2008) LEF-1 activates the transcription of E2F1. Biochem. Biophys. Res. Commun. 365, 149-153
41. Fedele, M., Pierantoni, G. M., Visone, R., and Fusco, A. (2006) E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression. Cell Div. 1, 17
42. Berkovich, E., and Ginsberg, D. (2001) Ras induces elevation of E2F-1 mRNA levels. J. Biol. Chem. 276, 42851-42856
43. Matsumura, I., Tanaka, H., and Kanakura, Y. (2003) E2F1 and c-Myc in cell growth and death. Cell Cycle 2, 333-338
44. Stanelle, J., and Pützer, B. M. (2006) E2F1-induced apoptosis: turning killers into therapeutics. Trends Mol. Med. 12, 177-185
45. Iaquinta, P. J., and Lees, J. A. (2007) Life and death decisions by the E2F transcription factors. Curr. Opin. Cell Biol. 19, 649-657
46. Hallstrom, T. C., and Nevins, J. R. (2006) Jab1 is a specificity factor for E2F1-induced apoptosis. Genes Dev. 20, 613-623
47. Lu, H., Liang, X., Issaenko, O. A., and Hallstrom, T. C. (2011) Jab1/CSN5 mediates E2F dependent expression of mitotic and apoptotic but notDNA replication targets. Cell Cycle 10, 3317-3326
48. Hallstrom, T. C., Mori, S., and Nevins, J. R. (2008) An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 13, 11-22
49. Engelmann, D., and Pützer, B. M. (2010) Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance. Drug Resist. Updat. 13, 119-131
50. Lee, T. J., Yao, G., Bennett, D. C., Nevins, J. R., and You, L. (2010) Stochastic E2F activation and reconciliation of phenomenological cell-cycle models. PLoS Biol. 8, e1000488
51. Imai, T., Horiuchi, A., Shiozawa, T., Osada, R., Kikuchi, N., Ohira, S., Oka, K., and Konishi, I. (2004) Elevated expression of E-cadherin and β-, β-, and β-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas. Hum. Pathol. 35, 1469-1476
52. Hans, C. P., Weisenburger, D. D., Vose, J. M., Hock, L. M., Lynch, J. C., Aoun, P., Greiner, T. C., Chan, W. C., Bociek, R. G., Bierman, P. J., and Armitage, J. O. (2003) A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood 101, 2363-2367
53. Novy, M., Pohn, R., Andorfer, P., Novy-Weiland, T., Galos, B., Schwarzmayr, L., and Rotheneder, H. (2005) EAPP, a novel E2F binding protein that modulates E2F-dependent transcription. Mol. Biol. Cell 16, 2181-2190
54. Andorfer, P., and Rotheneder, H. (2011) EAPP: gatekeeper at the crossroad of apoptosis and p21-mediated cell-cycle arrest. Oncogene 30, 2679-2690
55. Demetrius, L. (2005) Of mice and men: when it comes to studying ageing and the means to slow it down, mice are not just small humans. EMBO Rep. 6, S39-44
56. Wen, C. J., Xue, B., Qin, W. X., Yu, M., Zhang, M. Y., Zhao, D. H., Gao, X., Gu, J. R., and Li, C. J. (2004) hNRAGE, a human neurotrophin receptor interacting MAGE homologue, regulates p53 transcriptional activity and inhibits cell proliferation. FEBS Lett. 564, 171-176